Literature DB >> 19636711

The enhancing effect of ion-pairing on the skin permeation of glipizide.

Zhe Tan1, Jingying Zhang, Jian Wu, Liang Fang, Zhonggui He.   

Abstract

The purpose of the present study was to investigate the permeation of glipizide (GP) and observe the effect of an interaction with amines as counter ions, including diethylamine, triethylamine, ethanolamine, diethanolamine, triethanolamine, N-(2-hydroxylethyl) piperidine. Permeation experiments were performed in vitro, using rat abdominal skin as a barrier. The lipophilic donor system consisting of isopropyl myristate (IPM) and ethanol (EtOH; EI system, 8:2) produced a marked enhancement of GP flux through rat skin. All the amines investigated in this study had performed an enhancing effect on GP flux, and triethylamine had the most potent enhancing effect on GP in the vehicle IPM:EtOH = 8:2(w/w). In the presence of counter ions, the solubility of GP in the donor solution (IPM:EtOH = 8:2) was increased and the log K (o/w) of GP was decreased, which may due to higher solubility of the GP in the IPM:EtOH = 8:2(w/w). (13)C NMR spectroscopy was used to identify the ion-pairing formation between GP and the respective counter ion. It was surprising that all the four enhancers examined, such as isopropyl myristate, propylene glycol, N-methyl-2-pyrrolidone, azone, and oleic acid, had no enhancing effect on the percutaneous permeation of GP. This study showed that the formation of ion-pairs between GP and counter ions is a useful method to promote the skin permeation of GP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636711      PMCID: PMC2802175          DOI: 10.1208/s12249-009-9283-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  39 in total

1.  Ion pair skin transport of a zwitterionic drug, cephalexin.

Authors:  T Hatanaka; T Kamon; S Morigaki; K Katayama; T Koizumi
Journal:  J Control Release       Date:  2000-05-03       Impact factor: 9.776

2.  Pharmacological evaluation of membrane-moderated transdermal system of glipizide.

Authors:  Srinivas Mutalik; Nayanabhirama Udupa
Journal:  Clin Exp Pharmacol Physiol       Date:  2006 Jan-Feb       Impact factor: 2.557

3.  Synthesis and transdermal permeation-enhancing activity of ketone, amide, and alkane analogs of Transkarbam 12.

Authors:  Tomás Holas; Katerina Vávrová; Jana Klimentová; Alexandr Hrabálek
Journal:  Bioorg Med Chem       Date:  2006-01-11       Impact factor: 3.641

4.  Formation of ion-pairs in aqueous solutions of diclofenac salts.

Authors:  A Fini; G Fazio; M Gonzalez-Rodriguez; C Cavallari; N Passerini; L Rodriguez
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

5.  Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation.

Authors:  S R Gorukanti; L Li; K H Kim
Journal:  Int J Pharm       Date:  1999-12-10       Impact factor: 5.875

6.  Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol.

Authors:  Mohammad Abu Hena Mostofa Kamal; Nahoko Iimura; Tomohiro Nabekura; Shuji Kitagawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-04       Impact factor: 1.645

7.  Effect of application volume of ethanol-isopropyl myristate mixed solvent system on permeation of zidovudine and probenecid through rat skin.

Authors:  Y Jin; T Seki; Y Morimoto; K Juni
Journal:  Drug Dev Ind Pharm       Date:  2000-02       Impact factor: 3.225

8.  A transdermal delivery system for glipizide.

Authors:  H O Ammar; H A Salama; M Ghorab; S A El-Nahhas; H Elmotasem
Journal:  Curr Drug Deliv       Date:  2006-07       Impact factor: 2.565

9.  Transdermal delivery of tadalafil. I. Effect of vehicles on skin permeation.

Authors:  Gamal M El Maghraby; Fars Kaed Alanazi; Ibrahim A Alsarra
Journal:  Drug Dev Ind Pharm       Date:  2009-03       Impact factor: 3.225

10.  Ex vivo study of transdermal permeation of four diclofenac salts from different vehicles.

Authors:  Paola Minghetti; Francesco Cilurzo; Antonella Casiraghi; Luisa Montanari; Adamo Fini
Journal:  J Pharm Sci       Date:  2007-04       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.